Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Unternehmen & Branche
| Name | KESTRA MEDICAL TECHNOLOGIES, LTD. |
|---|---|
| Ticker | KMTS |
| CIK | 0001877184 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,15 Mrd. USD |
| Beta | 1,09 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-01-31 | 10-Q | 24,552,000 | -34,166,000 | -0.61 | 379,342,000 | |
| 2025-10-31 | 10-Q | 22,565,000 | -32,785,000 | -0.64 | 246,701,000 | |
| 2025-07-31 | 10-Q | 19,371,000 | -25,826,000 | -0.50 | 266,296,000 | |
| 2025-04-30 | 10-K | 59,815,000 | -113,814,000 | -5.13 | 295,744,000 | |
| 2025-01-31 | 10-Q | 15,090,000 | -21,509,000 | -1.25 | ||
| 2024-10-31 | 10-Q | 14,710,000 | -20,368,000 | -1.19 | ||
| 2024-07-31 | 10-Q | 12,782,000 | -19,884,000 | -1.12 | ||
| 2024-04-30 | 10-K | 27,814,000 | -94,120,000 | -5.07 | 45,949,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -15,000 | 20.04 | -300,670.50 | -124,7% | |
| 2026-03-26 | COHEN RAYMOND W | Director | Open Market Purchase | 10,000 | 19.98 | 199,800.00 | +82,8% | |
| 2026-03-17 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -15,000 | 20.27 | -304,123.50 | -126,1% | |
| 2026-02-17 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -11,635 | 25.39 | -295,455.70 | -122,5% | |
| 2026-02-17 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -93 | 27.18 | -2,527.64 | -1,0% | |
| 2026-02-17 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -3,272 | 26.29 | -86,036.26 | -35,7% | |
| 2026-01-15 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -15,000 | 22.80 | -342,024.00 | -141,8% | |
| 2025-12-29 | Webster Brian Daniel | Director, Officer, See Remarks | Open Market Sale | -15,000 | 26.59 | -398,847.00 | -165,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.